Caudal Versus Intravenous Magnesium Sulfate on Emergence Agitation After Sevoflurane In Children.
Emergence Agitation, Postoperative Pain
About this trial
This is an interventional prevention trial for Emergence Agitation focused on measuring Sevoflurane-, Emergence agitation, Magnesium sulfate, Children
Eligibility Criteria
Inclusion Criteria:
-All participants undergoing lower abdominal surgeries
Exclusion Criteria:
All participants with:-
- history of developmental delay,
- mental retardation,
- psychological disorders or
- Epilepsy which can make observational pain intensity assessment difficult,
- a known or suspect coagulopathy,
- a known allergy to any of the study drugs and
- any signs of infection at the site of the proposed caudal block.
Sites / Locations
- Marwa ibrahim mohamed abdo
Arms of the Study
Arm 1
Arm 2
Arm 3
Placebo Comparator
Experimental
Experimental
Bupivacaine (B group)
Magnesium sulfate caudal (MC group)
Magnesium sulfate I.V (M V group)
caudal block with bupivacaine 0.25% 1mg/kg diluted in 10 cm saline. + I.V injection of 10 cm saline over 10 mins then, I.V infusion 50 cm saline with rate 10-20 ml/h according to child weight.
caudal block with bupivacaine 0.25% 1mg/kg + Magnesium sulfate 50 mg diluted in 10 cm saline. + I.V injection of 10 cm saline over 10 mins then, I.V infusion of 50 cm saline with rate 10-20 ml/h according to child weight.
caudal block with bupivacaine 0.25% 1mg/kg diluted in 10 cm saline. + I.V injection of Magnesium sulfate 30mg/kg diluted in 10 cm saline over 10 mins then, I.V infusion one ampule of Magnesium sulfate 500mg diluted in 50 cm saline with rate 10 mg/kg/h.